UY29777A1 - Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión. - Google Patents
Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.Info
- Publication number
- UY29777A1 UY29777A1 UY29777A UY29777A UY29777A1 UY 29777 A1 UY29777 A1 UY 29777A1 UY 29777 A UY29777 A UY 29777A UY 29777 A UY29777 A UY 29777A UY 29777 A1 UY29777 A1 UY 29777A1
- Authority
- UY
- Uruguay
- Prior art keywords
- agomelatine
- depression
- patients
- treatment
- medicines
- Prior art date
Links
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002629 agomelatine Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 239000002689 soil Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0509207A FR2890562B1 (fr) | 2005-09-09 | 2005-09-09 | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles du sommeil chez le patient deprime |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29777A1 true UY29777A1 (es) | 2006-10-31 |
Family
ID=36200255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29777A UY29777A1 (es) | 2005-09-09 | 2006-08-31 | Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión. |
Country Status (26)
Country | Link |
---|---|
US (1) | US20070060655A1 (es) |
EP (2) | EP2295050A1 (es) |
JP (1) | JP2007077148A (es) |
KR (2) | KR20070029608A (es) |
CN (1) | CN1927193B (es) |
AP (1) | AP2008004379A0 (es) |
AR (1) | AR056063A1 (es) |
AU (1) | AU2006209372A1 (es) |
BR (1) | BRPI0603762A (es) |
CA (1) | CA2558762A1 (es) |
EA (1) | EA014288B1 (es) |
FR (1) | FR2890562B1 (es) |
GE (1) | GEP20094602B (es) |
GT (1) | GT200600409A (es) |
HK (1) | HK1100481A1 (es) |
MA (1) | MA28506B1 (es) |
MX (1) | MXPA06010233A (es) |
NO (1) | NO20064050L (es) |
NZ (1) | NZ549726A (es) |
PE (1) | PE20070333A1 (es) |
SG (1) | SG146451A1 (es) |
TW (1) | TW200800148A (es) |
UA (1) | UA81573C2 (es) |
UY (1) | UY29777A1 (es) |
WO (1) | WO2007028905A1 (es) |
ZA (1) | ZA200607531B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2918372B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2918370B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN102190594A (zh) * | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀氯化氢水合物及其制备方法 |
CN102190595A (zh) * | 2010-03-17 | 2011-09-21 | 上海医药工业研究院 | 阿戈美拉汀溴化氢水合物及其制备方法 |
CN101991559B (zh) * | 2010-11-25 | 2012-04-18 | 天津市汉康医药生物技术有限公司 | 一种稳定的阿戈美拉汀胶囊药物组合物 |
FR2978916B1 (fr) * | 2011-08-10 | 2013-07-26 | Servier Lab | Composition pharmaceutique solide pour administration buccale d'agomelatine |
WO2013119605A1 (en) * | 2012-02-07 | 2013-08-15 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Promoting sleep using at1 receptor blockers |
CN102552211B (zh) * | 2012-02-16 | 2013-07-17 | 福建广生堂药业股份有限公司 | 一种阿戈美拉汀的制剂组合物及其制备方法 |
EP2810647A1 (en) | 2013-06-06 | 2014-12-10 | Zentiva, a.s. | Pharmaceutical formulations comprising agomelatine in the form of agomelatine co-crystal with an organic acid |
PL2810656T3 (pl) | 2013-06-06 | 2018-01-31 | Zentiva Ks | Preparaty agomelatyny zawierające agomelatynę w postaci kokryształów |
EP2856934A1 (en) * | 2013-10-04 | 2015-04-08 | Les Laboratoires Servier | Biomarkers for the prediction of long term remission in depression |
CN103690499B (zh) * | 2013-12-23 | 2015-05-06 | 天津泰普药品科技发展有限公司 | 一种稳定的晶i型阿戈美拉汀片剂及其制备方法 |
CN103655499B (zh) * | 2013-12-23 | 2015-07-22 | 天津泰普药品科技发展有限公司 | 一种稳定的晶x型阿戈美拉汀片剂及其制备方法 |
CN104523639B (zh) * | 2014-12-11 | 2017-03-22 | 扬子江药业集团四川海蓉药业有限公司 | 一种阿戈美拉汀片剂及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2834890B1 (fr) * | 2002-01-23 | 2004-02-27 | Servier Lab | Composition pharmaceutique orodispersible d'agomelatine |
AU2004308962A1 (en) * | 2003-12-24 | 2005-07-14 | Sepracor Inc. | Melatonin combination therapy for improving sleep quality |
FR2866335B1 (fr) * | 2004-02-13 | 2006-05-26 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
US7645905B2 (en) * | 2005-08-03 | 2010-01-12 | Les Laboratoires Servier | Crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
US7358395B2 (en) * | 2005-08-03 | 2008-04-15 | Les Laboratories Servier | Crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
US7635721B2 (en) * | 2005-08-03 | 2009-12-22 | Les Laboratoires Servier | Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
-
2005
- 2005-09-09 FR FR0509207A patent/FR2890562B1/fr not_active Expired - Fee Related
-
2006
- 2006-08-22 MA MA29282A patent/MA28506B1/fr unknown
- 2006-08-29 CN CN2006101265880A patent/CN1927193B/zh not_active Expired - Fee Related
- 2006-08-31 SG SG200605975-2A patent/SG146451A1/en unknown
- 2006-08-31 UY UY29777A patent/UY29777A1/es unknown
- 2006-09-04 PE PE2006001068A patent/PE20070333A1/es not_active Application Discontinuation
- 2006-09-06 BR BRPI0603762-3A patent/BRPI0603762A/pt not_active IP Right Cessation
- 2006-09-07 NZ NZ549726A patent/NZ549726A/en not_active IP Right Cessation
- 2006-09-07 US US11/517,520 patent/US20070060655A1/en not_active Abandoned
- 2006-09-07 GE GEAP20069611A patent/GEP20094602B/en unknown
- 2006-09-08 EP EP10011610A patent/EP2295050A1/fr not_active Withdrawn
- 2006-09-08 TW TW095133158A patent/TW200800148A/zh unknown
- 2006-09-08 ZA ZA200607531A patent/ZA200607531B/xx unknown
- 2006-09-08 CA CA002558762A patent/CA2558762A1/fr not_active Abandoned
- 2006-09-08 AP AP2008004379A patent/AP2008004379A0/xx unknown
- 2006-09-08 EP EP06291422A patent/EP1762237A1/fr not_active Ceased
- 2006-09-08 UA UAA200609697A patent/UA81573C2/xx unknown
- 2006-09-08 AU AU2006209372A patent/AU2006209372A1/en not_active Abandoned
- 2006-09-08 NO NO20064050A patent/NO20064050L/no not_active Application Discontinuation
- 2006-09-08 EA EA200601449A patent/EA014288B1/ru not_active IP Right Cessation
- 2006-09-08 GT GT200600409A patent/GT200600409A/es unknown
- 2006-09-08 AR ARP060103908A patent/AR056063A1/es not_active Application Discontinuation
- 2006-09-08 MX MXPA06010233A patent/MXPA06010233A/es not_active Application Discontinuation
- 2006-09-08 WO PCT/FR2006/002068 patent/WO2007028905A1/fr active Application Filing
- 2006-09-11 JP JP2006245010A patent/JP2007077148A/ja active Pending
- 2006-09-11 KR KR1020060087713A patent/KR20070029608A/ko not_active Application Discontinuation
-
2007
- 2007-05-29 HK HK07105677.2A patent/HK1100481A1/xx not_active IP Right Cessation
-
2008
- 2008-10-31 KR KR1020080107661A patent/KR20080103043A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AP2008004379A0 (en) | 2008-04-30 |
JP2007077148A (ja) | 2007-03-29 |
NO20064050L (no) | 2007-03-12 |
EA014288B1 (ru) | 2010-10-29 |
TW200800148A (en) | 2008-01-01 |
NZ549726A (en) | 2008-03-28 |
KR20080103043A (ko) | 2008-11-26 |
CN1927193B (zh) | 2011-01-05 |
UA81573C2 (en) | 2008-01-10 |
EP1762237A1 (fr) | 2007-03-14 |
MA28506B1 (fr) | 2007-04-03 |
BRPI0603762A (pt) | 2007-05-15 |
CA2558762A1 (fr) | 2007-03-09 |
FR2890562B1 (fr) | 2012-10-12 |
FR2890562A1 (fr) | 2007-03-16 |
EP2295050A1 (fr) | 2011-03-16 |
WO2007028905A1 (fr) | 2007-03-15 |
KR20070029608A (ko) | 2007-03-14 |
US20070060655A1 (en) | 2007-03-15 |
GEP20094602B (en) | 2009-02-10 |
PE20070333A1 (es) | 2007-06-02 |
AR056063A1 (es) | 2007-09-19 |
SG146451A1 (en) | 2008-10-30 |
AU2006209372A1 (en) | 2007-03-29 |
CN1927193A (zh) | 2007-03-14 |
MXPA06010233A (es) | 2007-03-08 |
HK1100481A1 (en) | 2007-09-21 |
GT200600409A (es) | 2007-04-30 |
EA200601449A1 (ru) | 2007-04-27 |
ZA200607531B (en) | 2008-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY29777A1 (es) | Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos del sueno en pacientes con depresión. | |
PA8770101A1 (es) | Amidas de 4-aril-1,4-dihidro-1, 6-naftiridina sustituidas y su uso | |
BRPI0618239A8 (pt) | uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos | |
EA202091999A2 (ru) | Применение ингибиторов dpp iv | |
CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
MY157661A (en) | Bendamustine pharmaceutical compositions | |
EA201200975A1 (ru) | Тиено[2,3-b]пиридиндионовые активаторы амфк и их терапевтическое применение | |
MX2015002289A (es) | Anticuerpos humanos para gfr alfa 3 y métodos para su uso. | |
CL2008002545A1 (es) | Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor. | |
GT200800117A (es) | Nuevos derivados de furopirimidina aciclicos sustituidos y uso | |
UY33219A (es) | Cetoenoles cíclicos para terapias | |
CL2007002324A1 (es) | Compuestos derivados de 1h-quinolin-4-ona; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar o prevenir enfermedades asociadas con la modulacion del receptor gaba a, ansiedad, epilepsia, trastornos del sueno, insomnio, induccion de sedacion-hipnosis, anestesia y relajacion muscular. | |
UY31131A1 (es) | "oxazolidinonas sustituidas y su uso | |
AR057277A1 (es) | Utilizacion de agomelatina para la obtencion de medicamentos destinados al tratamiento de los trastornos bipolares | |
PA8800601A1 (es) | Productos quimioterapeuticos cristalinos | |
NZ598124A (en) | Compounds for treatment of inflammation | |
DK2155179T3 (da) | Axomadol til smertebehandling arthrose | |
AR061618A1 (es) | Formas de dosificacion unitaria de temozolomida | |
TN2012000256A1 (en) | Therapeutic use of protein-polymer conjugates | |
CL2008002195A1 (es) | Compuestos derivados de espiro ciclopentano; composicion farmaceutica que comprende a dichos compuestos; su proceso de preparacion; y su uso para tratar trastornos del sueño. | |
CU20070232A7 (es) | Utilización de la agomelatina para la obtención de medicamentos destinados al tratamiento de los trastornos bipolares | |
UY29247A1 (es) | Amidas de ácido pirazindicarboxílico y su uso | |
KR20100075783A (ko) | 허리 아픈데 사용하는 벨트 | |
DOP2005000168A (es) | Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas |